Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06434207
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-12
Brief Title:
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease Fetal-Maternal Regulation in Neonatal Thrombosis
Sponsor:
Boston Childrens Hospital
Organization:
Boston Childrens Hospital
Study Overview
Official Title:
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease Fetal-Maternal Regulation in Neonatal Thrombosis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EVmiRNA
Brief Summary:
Newborns with congenital heart disease CHD are at increased risk of developing postpartum and postoperative blood clots after cardiac surgery The molecular mechanisms that are responsible for the clotting profile predisposing children to blood clots in the early stages of life are currently not well described
The goal of this proposal is to prospectively collect plasma samples from ten 10 neonates with antenatal diagnosis of severe congenital heart disease CHD to better understand mechanisms responsible for abnormal clotting in the perioperative period
The goal of this proposal is to prospectively collect plasma samples from ten 10 neonates with antenatal diagnosis of severe congenital heart disease CHD to better understand mechanisms responsible for abnormal clotting in the perioperative period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None